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1726-4Mechanisms of the beneficial effects of Ger-Gen-Chyn-Lian-Tang
on acute and chronic liver injuryGer-Gen-Chyn-Lian-Tang (GGCLT), an officially stand-
ardized mixture of Chinese herbal medicines, consists of
Puerariae Radix, Scutellariae Radix, Coptidis Rhizoma, and
Glycyrrhizae Radix in a ratio of 8:3:3:2.1 In this issue of the
Journal of the Chinese Medical Association, Chang and his
colleagues1 evaluated the possible effects and mechanism of
GGCLT on thioacetamide (TAA)-induced hepatic injury and
fibrosis in mice. Incremental doses (30 mg/kg/day, 100 mg/kg/
day, and 300 mg/kg/day) of GGCLT were orally administered
to mice for as long as 6 weeks, similar to the intraperitoneal
TAA injection period as noted in Chang et al’s1 study. Con-
clusively, their study reported that chronic GGCLT treatment
effectively ameliorated hepatic fibrosis by decreasing hepatic
oxidative stress and modulating transforming growth factor
(TGF)-b/TGF-b receptor/smooth muscle a-actin signaling in
TAA mice.
Cumulative studies had reported the preventive effects of
Chinese medicine in experimental models and patients with
chronic hepatitis.2e9 The first active component of GGCLT,
pueratin (diadzein 8-C-glucoside) is the major isoflavonoid
derived from the Chinese medical herb Radix puerariae
(kudzu root). In China, R. puerariae is known as GeGen, and
has been used as a traditional medicine for treating various
diseases.2e6 The protective mechanisms of puerarin, at least in
part, are related to its ability to increase superoxide dismutase
activity, decrease lipid peroxidation, and enhance fibronol-
ysis.3 In mice, pretreatment with puerarin prior to admin-
istration of carbon tetrachloride (CCl4) substantially prevented
the elevation of liver function and hepatic malondialdehyde
(oxidants) formation in a dose-dependent manner. In addition,
pretreatment with puerarin significantly prevented both the
depletion of reduced glutathione (antioxidants) content and the
decrease in glutathione S-transferase activity, and histological
liver damage severity in the liver of CCl4-intoxicated mice.
4 In
rats with chronic alcohol-induced liver injury, the liver func-
tion test and proinflammatory cytokines were significantly
reduced following puerarin treatment. In addition, the
endogenous levels of tumor necrosis factor-a (TNF-a) and
nuclear factor-kB (NF-kB) proteins in the liver tissue were
effectively decreased following the puerarin treatment.
Together, these findings demonstrate that puerarin mediates
hepatoprotection against alcohol-induced liver injury by thex.doi.org/10.1016/j.jcma.2014.04.010
901/Copyright  2014 Elsevier Taiwan LLC and the Chinese Medical Assinhibition of inflammatory response and downregulation of the
TNFa/NFkB pathway, thereby maintaining metabolic
homeostasis in the liver.5 Additionally, chronic puerarin
treatment inhibits endotoxin gut leakage, Kupffer cell activa-
tion, endotoxin receptors expression, and alleviate chronic
alcoholic liver injury in rats.6
The second active component of GGCLT, baicalin is a
major bioactive flavonoid isolated from the radix of Scutel-
laria baicalensis GeorGi, which is widely used in traditional
Chinese medicine to treat inflammation.7 In mice, acute bai-
calin pretreatment protected against lipopolysaccharide/D-
galactosamine-induced liver injury, including dose-dependent
alleviation of mortality and hepatic pathological damage,
decrease of aspartate aminotransferase/alanine amino-
transferase release, inhibition of NFkB activity to reduce TNF-
a production and increase antioxidants.8 Moreover, baicalin
dose-dependently increased heme oxygenase (HO-1) protein
expression and activity. Further, inhibition of HO-1 activity
significantly reversed the protective effect of baicalin against
lipopolysaccharide/D-galactosamine-induced liver injury.8
Furthermore, acute baicalin treatment inhibited the typical
CCl4-induced liver damage portal inflammation, centrizonal
necrosis, and Kupffer cell hyperplasia, The beneficial effects
of baicalin protect hepatocytes by inhibition of the proin-
flammatory mediators, downregulation of TNF-a/inducible
nitric oxide synthase (iNOS) and upregulated HO-1 in mice.9
The antifibrotic effects of baicalin had also been reported to
act through the depression of peroxisomal proliferator-
activated receptor g in hepatic stellate cells.10
The third active component of GGCLT, berberine is an
active compound in Coptidis Rhizoma (Huanglian) with anti-
inflammatory and antioxidative stress effects.11 It had been
reported that acute berberine treatment possesses hep-
atoprotective effects against CCl4-induced hepatotoxicity by
increasing the hepatic superoxide dismutase activity.11 In vitro
study suggested that berberine effectively prevented CCl4-
induced liver fibrosis in mice by inducing cell cycle arrest in
G1 phase and a decrease in the number of activated hepatic
stellate cells.12
Licorice root is an herbal preparation that has been used to
reduce liver injury in a number of clinical disorders.13 The
forth active component of GGCLT, glycyrrhizin is theociation. All rights reserved.
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beneficial effects for patients with chronic hepatitis C.13 It had
been reported that acute administration of glycyrrhizin alle-
viates CCl4-induced acute liver injury, and this protection is
likely to be due to the induction of HO-1 and downregulation
of proinflammatory mediators.14 Potenlini is an injectable
compound whose active component is glycyrrhizin, which is
extracted from licorice. The results suggest that potenlini can
inhibit the NFkB binding activity in CCl4 and ethanol-induced
chronic liver injury and cirrhosis.15
Taking together, the protective effects of four components,
including puerariae, baicalin, berberine, and glycyrrhizin, of
GGCLT in acute and chronic liver injury are mainly mediated
by the inhibition of hepatic oxidative stress, TNFa/NFkB/
iNOS signal pathway, inflammatory mediator release, acti-
vated HSCs and upregulation of HO-1. In the Chang et al1
study, chronic GGCLT treatment prevented liver fibrosis by
the inhibition of various profibrogenic markers including
oxidative stress, NFkB, TGFb (receptor), and smooth muscle
a-actin (maker of the activated HSCs) in a TAA mice model.
Notably, the chronic effects of GGCLT in the TNFa/iNOS and
HO-1 signal pathway as well as inflammatory mediators
release should be further explored in future studies in a TAA
mice model. Nonetheless, the additional traditional herbal
medicines reported by Chang et al1 are noteworthy as potential
agents to treat hepatic fibrosis.
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